AGENUS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-12-31 was 0.00 shares.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2024-09-30 was 14.46K shares.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 17.00K shares, a 1.99% increase from fiscal 2024.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 16.67K shares, a 64.35% decline from fiscal 2023.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 46.75K shares, a 54.76% decline from fiscal 2022.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 103.34K shares, a 95.87% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 17.00K shares 10-K · filed 2026-03-16 | |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 16.67K shares 10-K · filed 2025-03-17 |
| 2024-09-30 | 14.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 46.75K shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 76.18K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 128.78K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 46.75K shares 10-Q · filed 2023-05-09 | 134.50K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 29.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 103.34K shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 52.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 162.23K shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 5.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 820.10K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 15.59K shares 10-Q · filed 2022-05-10 | 1.83M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 88.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 2.50M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 710.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 2.44M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 1.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 2.05M shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 691.60K shares 10-Q · filed 2021-05-07 | 1.33M shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-12-31 | 21.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 1.16M shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 322.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 1.56M shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 289.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 1.28M shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 527.88K shares 10-Q · filed 2020-05-11 | 994.53K shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 422.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 466.94K shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 43.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 44.23K shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 291.00 shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 291.00 shares 10-Q · filed 2019-05-10 | 291.00 shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 272.49K shares 10-K · filed 2019-03-18 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 315.12K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 386.87K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 272.49K shares 10-Q · filed 2018-05-10 | 399.10K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 42.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 160.32K shares 10-K · filed 2018-03-16 |
| 2017-09-30 | 71.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 143.07K shares derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-06-30 | 12.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 176.15K shares derived: sum of 4 quarters · filed 2017-08-07 |
| 2017-03-31 | 33.72K shares 10-Q · filed 2017-05-04 | 175.47K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 25.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 224.01K shares 10-K · filed 2017-03-16 |
| 2016-09-30 | 104.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 202.39K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 11.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 133.00K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 82.25K shares 10-Q · filed 2016-05-09 | 269.06K shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 3.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | 462.43K shares 10-K · filed 2016-03-15 |
| 2015-09-30 | 35.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | 494.28K shares derived: sum of 4 quarters · filed 2015-11-04 |
| 2015-06-30 | 147.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-03 | 458.84K shares derived: sum of 4 quarters · filed 2015-08-03 |
| 2015-03-31 | 275.62K shares 10-Q · filed 2015-05-01 | 311.22K shares derived: sum of 4 quarters · filed 2015-05-01 |
| 2014-12-31 | 35.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 48.38K shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 12.78K shares derived: sum of 4 quarters · filed 2014-10-31 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | 12.78K shares derived: sum of 4 quarters · filed 2014-08-01 |
| 2014-03-31 | 12.78K shares 10-Q · filed 2014-05-09 | 17.28K shares derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | 4.50K shares 10-K · filed 2014-03-07 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 5.07K shares derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-06-30 | 4.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 6.91K shares derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | |
| 2012-12-31 | 569.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 6.83K shares 10-K · filed 2013-03-18 |
| 2012-09-30 | 1.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |